首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

926044

預填充式注射器填充/完工服務市場 (2020～2030年)

Prefilled Syringe Fill / Finish Services Market, 2020-2030

出版日期: 2020年02月29日 | 出版商:

Roots Analysis | 英文 267 Pages | 商品交期: 最快1-2個工作天內

價格

全貌
簡介
目錄

簡介

預填充式注射器(及其他主要的藥物容器)的無菌藥的填充，認為是醫藥品製造流程中最重要的階段之一。無菌條件下實施的適當的填充/完工操作，不僅維持藥理效果和品質，還必須確保最終用戶的安全。

本報告提供全球預填充式注射器填充/完工服務市場未來展望相關分析，產品、服務的概要和市場基本結構，市場規模 (生產能力、需求量、市場收益額)的趨勢預測，各地區的詳細趨勢，主要企業的簡介和最新趨勢，資本交易、事業聯盟的動向，未來的市場機會，產業相關人員的見解等資訊彙整，為您概述為以下內容。

第1章簡介

第2章摘要整理

第3章簡介

分析概要
預填充式注射器的概要
- 預填充式注射器的優點
- 預填充式注射器的分類
- 預填充式注射器的製造方法
無菌注射劑的填充/完工工作的必要性
為預填充式注射器填充/完工市場成長貢獻的要素
預填充式注射器的填充/完工
- 預填充式注射器的填充/完工工作:主要的次序
- 填充、停止方法
- 注射器填充技術
為了選擇填充/完工服務業者的基本指南
填充/完工服務的外包的優點
填充/完工工作的外包的風險與課題

第4章市場環境

分析概要
預填充式注射器填充/完工服務業者:整體市場形勢
- 各成立年度分析
- 各企業規模分析
- 各產業規模分析
- 各總公司所在地分分析
- 填充/完工設備的各地點分析
- 企業規模、各藥物分子類型分析
- 注射器桶的各材質分析
- 各注射器的填充產量分析
- 各附加服務分析
- 網格表現:各成立年度、各企業規模、各藥物分子類型分析
- 標誌情勢:各企業規模、各藥物分子類型分析

第5章北美的預填充式注射器填充/完工服務業者:企業簡介

分析概要
Ajinomoto Bio-Pharma Services
- 企業概要
- 最近趨勢與未來展望
AMRI
BioPharma Solutions
Emergent BioSolutions
Patheon
PiSA Farmaceutica

第6章歐洲的預填充式注射器填充/完工服務業者:企業簡介

分析概要
Consort Medical
EVER Pharma
GlaxoSmithKline
IDT Biologika
Rentschler Biopharma
Siegfried
Vetter Pharma

第7章亞太地區的預填充式注射器填充/完工服務業者:企業簡介

分析概要
Biocon
Intas Pharmaceuticals
Kemwell Biopharma
Square Pharmaceuticals
USV

第8章預填充式注射器填充/完工服務業者:最近的趨勢

分析概要
事業聯盟模式
事業聯盟、合作的一覽
- 事業聯盟:各締結年度分析
- 事業聯盟:各種類的分析
- 各產業規模分析(資本交易限制)
- 各附加服務分析(資本交易限制)
- 最活躍的企業:事業聯盟的締結數量分析
事業擴張的一覽
- 事業擴張:各實施年度分析
- 事業擴張:各種類的分析
- 事業擴張:各產業規模分析
- 事業聯盟:擴張計劃的各地方分析
- 事業聯盟:關係的各藥物分子類型分析
- 各附加服務分析(事業擴張限制)

第9章容量分析

分析概要
分析的前提條件與手法
全球預填充式注射器的填充/完工設施:數量
- 各企業規模分析(廠商)
- 各產業規模分析
- 各總公司所在地分析
- 填充/完工設備的各地點分析
- 各藥物分子類型分析
全球預填充式注射器的填充/完工設施:容量
- 各企業規模分析(廠商)
- 各產業規模分析
- 各總公司所在地分析
- 填充/完工設備的各地點分析
- 各藥物分子類型分析

第10章需求分析

分析概要
分析的前提條件與手法
預填充式注射器的填充/完工服務的世界需求
- 各地區的分析
- 各藥物分子類型分析
- 治療領域的各分析
- 注射器桶的各材質分析
- 各桶室數分析
需求與供給趨勢分析

第11章需求與供給趨勢的各地區評估

分析概要
北美的供需趨勢的評估
歐洲的供需趨勢的評估
亞太地區、其他國家 (RoW)的供需趨勢的評估

第12章有可能性的合作夥伴分析

分析概要
分析方法和主要指標
可能性高的合作夥伴分析
- 北美的機會
- 歐洲的機會
- 在亞太地區、其他國家 (RoW) 的機會

第13章市場規模、機會分析

分析概要
預測手法主要的前提條件
預填充式注射器填充/完工服務:市場規模 (全球，2020～2030年)
- 各經營規模 (2020～2030年)
- 各地點 (2020～2030年)
- 各藥物分子類型 (2020～2030年)
- 各治療領域 (2020～2030年)
- 各注射器桶材料 (2020～2030年)
- 各桶室數 (2020～2030年)

第14章成長機會

分析概要
擴大中的注射藥開發平台
填充/完工工作的外包增加
自體治療的上升趨勢
預填充式注射器的人氣增加
無菌填充/完工技術的進步

第15章預填充式注射器廠商

分析概要
預填充式注射器:可利用的/開發中的設備的一覽
- 各注射器桶材質
- 各桶室數
- 針系統的各類型
- 各桶音量
預填充式注射器:製造商清單
- 各成立年度分析
- 各企業規模分析
- 各總公司所在地分析

第16章結論

第17章企業員工的見解:概要

分析概要
Intas Pharmaceuticals
- 公司概要
- 受訪者的姓名、職位與回答內容 (概要)
IDT Biologika
IDEO
Syngene
大CMO (受託製造廠商)

第18章附錄1:資料表

第19章附錄2:企業的一覽

Overview:

Among drug delivery devices, prefilled syringes represent one of the fastest growing primary packaging formats, which are also designed for dose administration. In fact, over the past ten years, there has been an evident increase in the development of parenteral drugs (especially with the introduction of several classes of biologics), which has resulted in an increased consumption of prefilled syringes, by approximately three fold. The sustained preference for such products can be attributed to the fact that prefilled syringes are safe and easy-to-use, and current variants are designed with provisions to reduce dosing errors, the risk of occlusions, extravasation and phlebitis. Owing to the aforementioned benefits, several injectable drugs (such as Humira®, Enbrel®, Avastin®, PREVNAR 13®, ALPROLIX® and Benefix®), diluents and other products requiring parenteral administration, are packaged in prefilled syringes. In fact, over the past seven years, around 90 drugs have been approved in combination with prefilled syringes across different geographies, including the North America, Europe and Asia-Pacific. Moreover, several clinical-stage drugs are being evaluated in combination with prefilled syringes, across different phases of development.

The filling of sterile drugs into prefilled syringes (and other primary drug containers) is considered to be one of the most crucial steps in the pharmaceutical production process. Proper fill / finish operations, carried out under aseptic conditions, is a necessity for not only maintaining pharmacological efficacy and quality, but also ensuring end user safety. The prefilled syringe filling operation is considered complex as it requires close monitoring of both the syringe fill volume as well as the headspace between the liquid in the syringe and the bottom of the plunger. Additionally, the rise in complexity of small molecule APIs and the increasing diversity of biologic drugs have also contributed towards the demand of advanced aseptic fill / finish operations. A number of small-sized companies and some large companies have outsourced their fill / finish operations to contract service providers. According to the 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, biomanufacturers have been shown to outsource over 30% of their fill / finish operations. With the increase in the demand for prefilled syringes, along with the growing complexity of fill / finish processes, the outsourcing of these operations is likely to increase further in the future. Currently, over 100 companies are actively providing fill / finish services for prefilled syringes. In order to cope up with the current and future market demand, service providers are actively investing in expanding their existing infrastructure and capabilities; companies are also expanding their client reach through service agreements in the past few years. Given that around 55% of drug candidates in the global R&D pipeline are injectables, the opportunities for prefilled syringe developers / manufacturers and affiliated service providers is anticipated to continue to grow over the next decade. In addition, owing to the recent COVID-19 pandemic, an increase in the development initiatives for the vaccines is likely to be witnessed in the near future. This is expected to significantly raise the demand for prefilled syringes, providing an additional impetus to the overall fill / finish services market.

The 'Prefilled Syringe Fill / Finish Service Providers, 2020-2030' report features an extensive study of the current market landscape and future opportunities for contract service providers offering fill finish services for prefilled syringes.

1. PREFACE

1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview
3.2. Introduction to Prefilled Syringes
- 3.2.1. Advantages of Prefilled Syringes
  - 3.2.1.1. Benefits to Healthcare Professionals and End Users
  - 3.2.1.2. Benefits to Manufacturers
- 3.2.2. Classification of Prefilled Syringes
- 3.2.3. Manufacturing of Prefilled Syringes
3.3. Need for Outsourcing Fill / Finish Operations of Sterile Injectables
3.4. Factors Contributing to the Growth of Prefilled Syringe Fill / Finish Market
3.5. Fill / Finish of Prefilled Syringes
- 3.5.1. Key Steps in Fill / Finish Operations of Prefilled Syringes
- 3.5.2. Filling and Stoppering Methods
- 3.5.3. Syringe Filling Technologies
3.6. Basic Guidelines for Selecting a Fill / Finish Service Provider
3.7. Advantages of Outsourcing Fill / Finish Services
3.8. Risks and Challenges of Outsourcing Fill / Finish Operations

4. MARKET LANDSCAPE

4.1. Chapter Overview
4.2. Prefilled Syringe Fill / Finish Service Providers: Overall Market Landscape
- 4.2.1. Analysis by Year of Establishment
- 4.2.2. Analysis by Company Size
- 4.2.3. Analysis by Scale of Operation
- 4.2.4. Analysis by Location of Headquarters
- 4.2.5. Analysis by Location of Fill / Finish Facilities
- 4.2.6. Analysis by Company Size and Type of Drug Molecule
- 4.2.7. Analysis by Syringe Barrel Material
- 4.2.8. Analysis by Syringe Fill Volume
- 4.2.9. Analysis by Additional Services Offered
- 4.2.10. Grid Representation: Analysis by Year of Establishment, Company Size and Type of Drug Molecule
- 4.2.11. Logo Landscape: Analysis by Company Size and Type of Drug Molecule
  - 4.2.5.1. World Map Representation: Analysis by Scale of operation and Location of Fill / Finish Facility

5. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES

5.1. Chapter Overview
5.2. Ajinomoto Bio-Pharma Services
- 5.2.1. Company Overview
- 5.2.2. Recent Developments and Future Outlook
5.3. AMRI
- 5.3.1. Company Overview
- 5.3.2. Recent Developments and Future Outlook
5.4. BioPharma Solutions
- 5.4.1. Company Overview
- 5.4.2. Recent Developments and Future Outlook
5.5. Emergent BioSolutions
- 5.5.1. Company Overview
- 5.5.2. Recent Developments and Future Outlook
5.6. Patheon
- 5.6.1. Company Overview
- 5.6.2. Recent Developments and Future Outlook
5.7. PiSA Farmacéutica
- 5.7.1. Company Overview
- 5.7.2. Recent Developments and Future Outlook

6. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN EUROPE: COMPANY PROFILES

6.1. Chapter Overview
6.2. Consort Medical
- 6.2.1. Company Overview
- 6.2.2. Recent Developments and Future Outlook
6.3. EVER Pharma
- 6.3.1. Company Overview
- 6.3.2. Recent Developments and Future Outlook
6.4. GlaxoSmithKline
- 6.4.1. Company Overview
- 6.4.2. Recent Developments and Future Outlook
6.5. IDT Biologika
- 6.5.1. Company Overview
- 6.5.2. Recent Developments and Future Outlook
6.6. Rentschler Biopharma
- 6.6.1. Company Overview
- 6.6.2. Recent Developments and Future Outlook
6.7. Siegfried
- 6.7.1. Company Overview
- 6.7.2. Recent Developments and Future Outlook
6.8. Vetter Pharma
- 6.8.1. Company Overview
- 6.8.2. Recent Developments and Future Outlook

7. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC: COMPANY PROFILES

7.1. Chapter Overview
7.2. Biocon
- 7.2.1. Company Overview
- 7.2.2. Recent Developments and Future Outlook
7.2. Intas Pharmaceuticals
- 7.2.1. Company Overview
- 7.2.2. Recent Developments and Future Outlook
7.3. Kemwell Biopharma
- 7.3.1. Company Overview
- 7.3.2. Recent Developments and Future Outlook
7.4. Square Pharmaceuticals
- 7.4.1. Company Overview
- 7.4.2. Recent Developments and Future Outlook
7.5. USV
- 7.5.1. Company Overview
- 7.5.2. Recent Developments and Future Outlook

8. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS: RECENT DEVELOPMENTS

8.1. Chapter Overview
8.2. Partnership Models
8.3 List of Partnerships and Collaborations
- 8.3.1. Analysis by Year of Partnership
- 8.3.2. Analysis by Type of Partnership
- 8.3.3. Analysis by Scale of Operation (Deal Specific)
- 8.3.5. Analysis by Additional Services Offered (Deal Specific)
- 8.3.6. Most Active Players: Analysis by Number of Partnerships
8.4. List of Expansions
- 8.4.1. Analysis by Year of Expansion
- 8.4.2. Analysis by Type of Expansion
- 8.4.3. Analysis by Expanded Scale of Operation
- 8.4.4. Analysis by Location of Expansion Project
- 8.4.5. Analysis by Type of Drug Molecule Involved
- 8.4.6. Analysis by Additional Services Offered (Expansion Specific)

9. CAPACITY ANALYSIS

9.1. Chapter Overview
9.2. Assumptions and Methodology
9.3. Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units)
- 9.3.1. Analysis by Company Size (Manufacturer)
- 9.3.2. Analysis by Scale of Operation
- 9.3.3. Analysis by Location of Headquarters
- 9.3.4. Analysis by Location of Fill / Finish Facilities
- 9.3.5. Analysis by Type of Drug Molecule
9.4. Global, Prefilled Syringe Fill / Finish Capacity (by Volume)
- 9.4.1. Analysis by Company Size (Manufacturer)
- 9.4.2. Analysis by Scale of Operation
- 9.4.3. Analysis by Location of Headquarters
- 9.4.4. Analysis by Location of Fill / Finish Facilities
- 9.4.5. Analysis by Type of Drug Molecule

10. DEMAND ANALYSIS

10.1. Chapter Overview
10.2. Assumptions and Methodology
10.3. Global Demand for Prefilled Syringe Fill / Finish Services
- 10.3.1. Analysis by Geography
- 10.3.2. Analysis by Type of Drug Molecule
- 10.3.3. Analysis by Therapeutic Area
- 10.3.4. Analysis by Syringe Barrel Material
- 10.3.5. Analysis by Number of Barrel Chambers
10.4. Analysis of Demand and Supply Dynamics

11. GEOGRAPHICAL ASSESSMENT OF DEMAND AND SUPPLY

11.1. Chapter Overview
11.2. Demand and Supply Assessment in North America
11.3. Demand and Supply Assessment in Europe
11.4. Demand and Supply Assessment in Asia-Pacific and Rest of the World

12. LIKELY PARTNER ANALYSIS

12.1. Chapter Overview
12.2. Methodology and Key Parameters
12.3. Likely Partner Analysis
- 12.3.1. Opportunities in North America
  - 12.3.1.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
  - 12.3.1.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
- 12.3.2. Opportunities in Europe
  - 12.3.2.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
  - 12.3.2.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
- 12.3.3. Opportunities in Asia-Pacific and Rest of the World
  - 12.3.3.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
  - 12.3.3.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers

13. MARKET SIZING AND OPPORTUNITY ANALYSIS

13.1. Chapter Overview
13.2. Forecast Methodology and Key Assumptions
13.3. Overall Prefilled Syringe Fill / Finish Services Market, 2020-2030
- 13.3.1. Prefilled Syringe Fill / Finish Services Market: Distribution by Scale of Operation, 2020-2030
- 13.3.2. Prefilled Syringe Fill / Finish Services Market: Distribution by Geographical Location, 2020-2030
- 13.3.3. Prefilled Syringe Fill / Finish Services Market: Distribution by Type of Drug Molecule, 2020-2030
- 13.3.4. Prefilled Syringe Fill / Finish Services Market: Distribution by Therapeutic Area, 2020-2030
- 13.3.5. Prefilled Syringe Fill / Finish Services Market: Distribution by Syringe Barrel Material, 2020-2030
- 13.3.6. Prefilled Syringe Fill / Finish Services Market: Distribution by Number of Barrel Chambers, 2020-2030

14. FUTURE GROWTH OPPORTUNITIES

14.1. Chapter Overview
14.2. Growing Injectable Drugs Pipeline
14.3. Increase in Outsourcing of Fill / Finish Activities
14.4. Rising Preference for Self-Medication
14.5. Increase in Popularity of Prefilled Syringes
14.6. Advances in Aseptic Fill / Finish Technologies

15. PREFILLED SYRINGE MANUFACTURERS

15.1. Chapter Overview
15.2. Prefilled Syringes: List of Available / Under Development Devices
- 15.2.1. Analysis by Syringe Barrel Material
- 15.2.2. Analysis by Number of Barrel Chambers
- 15.2.3. Analysis by Type of Needle System
- 15.2.4. Analysis by Barrel Volume
15.3. Prefilled Syringes: List of Manufacturers
- 15.3.1. Analysis by Year of Establishment
- 15.3.2. Analysis by Company Size
- 15.3.3. Analysis by Location of Headquarters

16. CONCLUDING REMARKS

16.1. Chapter Overview
16.2. Key Takeaways

17. INTERVIEW TRANSCRIPTS

17.1. Chapter Overview
17.2. Intas Pharmaceuticals
- 17.2.1. Company Snapshot
- 17.2.2. Interview Transcript: Kirti Maheshwari, Chief Technical Officer
17.3. IDT Biologika
- 17.3.1. Company Snapshot
- 17.3.2. Interview Transcript: Gregor Kawaletz, Chief Commercial Officer
17.4. IDEO
- 17.4.1. Company Snapshot
- 17.4.2. Interview Transcript: Jesse Fourt, Design Director
17.5. Syngene
- 17.5.1. Company Snapshot
- 17.5.2. Interview Transcript: Purushottam Singnurkar, Research Director and Head of Formulation Development
17.6. Large CMO
- 17.6.1. Interview Transcript: Anonymous, Associate Director, Head of Process Sciences Formulation and Fill / Finish

18. APPENDIX 1: TABULATED DATA

19. APPENDIX 2: LIST OF COMPANIES

List Of Figures

Figure 3.1 Steps Involved in the Manufacturing of Prefilled Syringes
Figure 3.2 Steps Involved in Fill / Finish Operations of Prefilled Syringes
Figure 3.3 Key Considerations for Selecting a CMO Partner
Figure 3.4 Risks and Challenges Associated with Outsourcing Fill / Finish Operations
Figure 4.1 Prefilled Syringe Fill / Finish Service Providers: Distribution by Year of Establishment
Figure 4.2 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size
Figure 4.3 Prefilled Syringe Fill / Finish Service Providers: Distribution by Scale of Operation
Figure 4.4 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Headquarters
Figure 4.5 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Figure 4.6 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size and Type of Drug Molecule
Figure 4.7 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Barrel Material
Figure 4.8 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Fill Volume
Figure 4.9 Prefilled Syringe Fill / Finish Service Providers: Distribution by Additional Services Offered
Figure 4.10 Grid Representation: Distribution by Year of Establishment, Company Size and Type of Drug Molecule
Figure 4.11 Logo Landscape: Distribution by Company Size and Type of Drug Molecule
Figure 4.12 World Map Representation: Distribution by Scale of Operation and Location of Fill / Finish Facility
Figure 8.1 Partnerships and Collaborations: Distribution by Year of Partnership, 2015-2019
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Scale of Operation (Deal Specific)
Figure 8.4 Partnerships and Collaborations: Distribution by Additional Services Offered (Deal Specific)
Figure 8.5 Most Active Players: Distribution by Number of Partnerships
Figure 8.6 Expansions: Distribution by Year of Expansion, 2015-2019
Figure 8.7 Expansions: Distribution by Type of Expansion
Figure 8.8 Expansions: Distribution by Expanded Scale of Operation
Figure 8.9 Expansions: Distribution by Location of Expansion Project
Figure 8.10 Expansions: Distribution by Type of Drug Molecule Involved
Figure 8.11 Expansions: Distribution by Additional Services Offered (Expansion Specific)
Figure 9.1 Global, Prefilled Syringe Fill / Finish Capacity: Distribution of Capacity by Size of Manufacturer (Sample Data Set)
Figure 9.2 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size of Manufacturer (in Million Units)
Figure 9.3 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Scale of Operation (in Million Units)
Figure 9.4 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Headquarters (in Million Units)
Figure 9.5 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Fill / Finish Facilities (in Million Units)
Figure 9.6 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Type of Drug Molecule (in Million Units)
Figure 9.7 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size of Manufacturer (in Million Liters)
Figure 9.8 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Scale of Operation (in Million Liters)
Figure 9.9 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Headquarters (in Million Liters)
Figure 9.10 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Fill / Finish Facilities (in Million Liters)
Figure 9.11 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Type of Drug Molecule (in Million Liters)
Figure 10.1 Global, Demand for Prefilled Syringe Fill / Finish Services
Figure 10.2 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Geography
Figure 10.3 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Type of Drug Molecule
Figure 10.4 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Therapeutic Area
Figure 10.5 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Syringe Barrel Material
Figure 10.6 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Number of Barrel Chambers
Figure 10.7 Global, Prefilled Syringe Fill / Finish Services: Demand and Supply Dynamics
Figure 11.1 Demand and Supply Assessment: North America
Figure 11.2 Demand and Supply Assessment: Europe
Figure 11.3 Demand and Supply Assessment: Asia-Pacific and Rest of the World
Figure 12.1 Likely Partner Analysis: Distribution by Geography
Figure 13.1. Overall Prefilled Syringe Fill / Finish Services Market, 2020-2030 (USD Billion)
Figure 13.2. Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Scale of Operation (USD Million)
Figure 13.3. Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Geographical Location (USD Million)
Figure 13.4. Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Type of Drug Molecule (USD Million)
Figure 13.5. Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Therapeutic Area (USD Million)
Figure 13.6. Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Syringe Barrel Material (USD Million)
Figure 13.7. Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Number of Barrel Chambers (USD Million)
Figure 14.1. Growth Opportunities for Prefilled Syringe Fill / Finish Service Providers
Figure 15.1 Prefilled Syringes: Distribution by Syringe Barrel Material
Figure 15.2 Prefilled Syringes: Distribution by Number of Barrel Chambers
Figure 15.3 Prefilled Syringes: Distribution by Type of Needle System
Figure 15.4 Prefilled Syringes: Distribution by Barrel Volume
Figure 15.5 Prefilled Syringe Manufacturers: Distribution by Year of Establishment
Figure 15.6 Prefilled Syringe Manufacturers: Distribution by Company Size
Figure 15.7 Prefilled Syringe Manufacturers: Distribution by Location of Headquarters

List Of Tables

Table 3.1 Classification of Prefilled Syringes
Table 4.1 Prefilled Syringe Fill / Finish Service Providers: List of Companies
Table 4.2 Prefilled Syringe Fill / Finish Service Providers: Information on Location of Fill / Finish Facilities
Table 4.3 Prefilled Syringe Fill / Finish Service Providers: Information on Type of Drug Molecule
Table 4.4 Prefilled Syringe Fill / Finish Service Providers: Information on Syringe Barrel Material
Table 4.5 Prefilled Syringe Fill / Finish Service Providers: Information on Syringe Fill Volume Range
Table 4.6 Prefilled Syringe Fill / Finish Service Providers: Information on Additional Services Offered
Table 4.6 Prefilled Syringe Fill / Finish Service Providers: Information on Fill / Finish Capability
Table 5.1 Ajinomoto Bio-Pharma Services: Company Snapshot
Table 5.2 Ajinomoto Bio-Pharma Services: Recent Developments and Future Outlook
Table 5.3 AMRI: Company Snapshot
Table 5.4 AMRI: Recent Developments and Future Outlook
Table 5.5 BioPharma Solutions: Company Snapshot
Table 5.6 BioPharma Solutions: Recent Developments and Future Outlook
Table 5.7 Emergent BioSolutions: Company Snapshot
Table 5.8 Emergent BioSolutions: Recent Developments and Future Outlook
Table 5.9 Patheon: Company Snapshot
Table 5.10 Patheon: Recent Developments and Future Outlook
Table 5.11 PiSA Farmacéutica: Company Snapshot
Table 5.12 PiSA Farmacéutica: Recent Developments and Future Outlook
Table 6.1 Consort Medical: Company Snapshot
Table 6.2 Consort Medical: Recent Developments and Future Outlook
Table 6.3 EVER Pharma: Company Snapshot
Table 6.4 EVER Pharma: Recent Developments and Future Outlook
Table 6.5 GlaxoSmithKline: Company Snapshot
Table 6.6 GlaxoSmithKline: Recent Developments and Future Outlook
Table 6.7 IDT Biologika: Company Snapshot
Table 6.8 IDT Biologika: Recent Developments and Future Outlook
Table 6.9 Rentschler Biopharma: Company Snapshot
Table 6.10 Rentschler Biopharma: Recent Developments and Future Outlook
Table 6.11 Siegfried: Company Snapshot
Table 6.12 Siegfried: Recent Developments and Future Outlook
Table 6.13 Vetter Pharma: Company Snapshot
Table 6.14 Vetter Pharma: Recent Developments and Future Outlook
Table 7.1 Biocon: Company Snapshot
Table 7.2 Biocon: Recent Developments and Future Outlook
Table 7.3 Intas Pharmaceuticals: Company Snapshot
Table 7.4 Intas Pharmaceuticals: Recent Developments and Future Outlook
Table 7.5 Kemwell Biopharma: Company Snapshot
Table 7.6 Kemwell Biopharma: Recent Developments and Future Outlook
Table 7.7 Square Pharmaceuticals: Company Snapshot
Table 7.8 Square Pharmaceuticals: Recent Developments and Future Outlook
Table 7.9 USV: Company Snapshot
Table 7.10 USV: Recent Developments and Future Outlook
Table 8.1 Prefilled Syringe Fill / Finish Service Providers: Partnerships and Collaborations, 2015-2019
Table 8.2 Prefilled Syringe Fill / Finish Service Providers: Recent Expansions, 2015-2019
Table 9.1 Global Prefilled Syringe Fill / Finish Capacity (by Number of Units): Average Capacity by Company Size of Manufacturer (Sample Data Set)
Table 12.1 Opportunities in North America: Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
Table 12.2 Opportunities in North America: Likely Partners for Prefilled Syringe Fill / Finish Service Providers
Table 12.3 Opportunities in Europe: Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
Table 12.4 Opportunities in Europe: Likely Partners for Prefilled Syringe Fill / Finish Service Providers
Table 12.5 Opportunities in Asia-Pacific and Rest of the World: Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
Table 12.6 Opportunities in Asia-Pacific and Rest of the World: Likely Partners for Prefilled Syringe Fill / Finish Service Providers
Table 15.1 Prefilled Syringes: List of Available / Under Development Devices
Table 16.1 Prefilled Syringe Fill / Finish Services Market: Key Takeaways
Table 17.1 Intas Pharmaceuticals: Key Highlights
Table 17.2 IDT Biologika: Key Highlights
Table 17.3 IDEO: Key Highlights
Table 17.4 Syngene: Key Highlights
Table 18.1 Prefilled Syringe Fill / Finish Service Providers: Distribution by Year of Establishment
Table 18.2 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size
Table 18.3 Prefilled Syringe Fill / Finish Service Providers: Distribution by Scale of Operation
Table 18.4 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Headquarters
Table 18.5 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Table 18.6 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size and Type of Drug Molecule
Table 18.7 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Barrel Material
Table 18.8 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Fill Volume
Table 18.9 Prefilled Syringe Fill / Finish Service Providers: Distribution by Additional Services Offered
Table 18.10 Partnerships and Collaborations: Distribution by Year of Partnership, 2015-2019
Table 18.11 Partnerships and Collaborations: Distribution by Type of Partnership
Table 18.12 Partnerships and Collaborations: Distribution by Scale of Operation (Deal Specific)
Table 18.13 Partnerships and Collaborations: Distribution by Additional Services Offered (Deal Specific)
Table 18.14 Most Active Players: Distribution by Number of Partnerships
Table 18.15 Expansions: Distribution by Year of Expansion, 2015-2019
Table 18.16 Expansions: Distribution by Type of Expansion
Table 18.17 Expansions: Distribution by Expanded Scale of Operation
Table 18.18 Expansions: Distribution by Location of Expansion Project
Table 18.19 Expansions: Distribution by Type of Drug Molecule Involved
Table 18.20 Expansions: Distribution by Additional Services Offered (Expansion Specific)
Table 18.21 Global, Prefilled Syringe Fill / Finish Capacity: Distribution of Capacity by Size of Manufacturer (Sample Data Set)
Table 18.22 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size of Manufacturer (in Million Units)
Table 18.23 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Scale of Operation (in Million Units)
Table 18.24 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Headquarters (in Million Units)
Table 18.25 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Fill / Finish Facilities (in Million Units)
Table 18.26 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Type of Drug Molecule (in Million Units)
Table 18.27 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size of Manufacturer (in Million Liters)
Table 18.28 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Scale of Operation (in Million Liters)
Table 18.29 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Headquarters (in Million Liters)
Table 18.30 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Fill / Finish Facilities (in Million Liters)
Table 18.31 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Type of Drug Molecule (in Million Liters)
Table 18.32 Global, Demand for Prefilled Syringe Fill / Finish Services
Table 18.33 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Geography
Table 18.34 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Type of Drug Molecule
Table 18.35 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Therapeutic Area
Table 18.36 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Syringe Barrel Material
Table 18.37 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Number of Barrel Chambers
Table 18.38 Demand and Supply Assessment: North America
Table 18.39 Demand and Supply Assessment: Europe
Table 18.40 Demand and Supply Assessment: Asia-Pacific and Rest of the World
Table 18.41 Likely Partner Analysis: Distribution by Geography
Table 18.42 Overall Prefilled Syringe Fill / Finish Services Market, Conservative, Base and Optimistic Scenarios, 2020-2030 (USD Billion)
Table 18.43 Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios, (USD Million)
Table 18.44 Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Geographical Location, Conservative, Base and Optimistic Scenarios, (USD Million)
Table 18.45 Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Type of Drug Molecule, Conservative, Base and Optimistic Scenarios, (USD Million)
Table 18.46 Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios, (USD Million)
Table 18.47 Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Syringe Barrel Material, Conservative, Base and Optimistic Scenarios, (USD Million)
Table 18.48 Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Number of Barrel Chambers, Conservative, Base and Optimistic Scenarios, (USD Million)
Table 18.49 Prefilled Syringes: Distribution by Syringe Barrel Material
Table 18.50 Prefilled Syringes: Distribution by Number of Barrel Chambers
Table 18.51 Prefilled Syringes: Distribution by Type of Needle System
Table 18.52 Prefilled Syringes: Distribution by Barrel Volume
Table 18.53 Prefilled Syringe Manufacturers: Distribution by Year of Establishment
Table 18.54 Prefilled Syringe Manufacturers: Distribution by Company Size
Table 18.55 Prefilled Syringe Manufacturers: Distribution by Location of Headquarters